Rapid communication Open Access
Like 0


On 20 November 2019, Lassa fever was diagnosed in a physician repatriated from Sierra Leone to the Netherlands. A second physician with suspected Lassa fever, repatriated a few days later from the same healthcare facility, was confirmed infected with Lassa virus on 21 November. Comprehensive contact monitoring involving high- and low-risk contacts proved to be feasible and follow-up of the contacts did not reveal any case of secondary transmission in the Netherlands.


Article metrics loading...

Loading full text...

Full text loading...



  1. National Coordination Centre for Communicable Disease Control (LCI). Virale hemorragische koorts – arenavirussen. [Viral haemorrhagic fevers caused by arenaviruses]. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2019. Dutch. Available from: https://lci.rivm.nl/richtlijnen/virale-hemorragische-koorts-arenavirussen
  2. Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill. 2014;19(21):20817.  https://doi.org/10.2807/1560-7917.ES2014.19.21.20817  PMID: 24906375 
  3. Timen A, Koopmans MP, Vossen AC, van Doornum GJ, Günther S, van den Berkmortel F, et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis. 2009;15(8):1171-5.  https://doi.org/10.3201/eid1508.090015  PMID: 19751577 
  4. van Steenbergen J, Wijnands S. Public health management of fatal case of Lassa fever in the Netherlands. Euro Surveill. 2000;4(31):1552.
  5. Veldkamp PJ, Schippers EF. Een man met fatale Lassa-koorts na een verblijf in Sierra Leone. [A man with fatal Lassa fever following a stay in Sierra Leone.] Ned Tijdschr Geneeskd. 2002;146(46):2201-4. Dutch. PMID: 12467165 
  6. World Health Organization (WHO). Lassa fever. Fact sheet. Geneva: WHO; 2017. http://origin.who.int/mediacentre/factsheets/fs179/en/
  7. Okogbenin S, Okoeguale J, Akpede G, Colubri A, Barnes KG, Mehta S, et al. Retrospective cohort study of Lassa fever in pregnancy, Southern Nigeria. Emerg Infect Dis. 2019;25(8):1494-500.  https://doi.org/10.3201/eid2508.181299  PMID: 31310586 
  8. World Health Organization (WHO). Lassa fever – the Netherlands (ex –Sierra Leone). Geneva: WHO; 2019. Available from: https://www.who.int/csr/don/27-november-2019-lassa-fever-netherlands_sierra_leone/en/
  9. Garnett LE, Strong JE. Lassa fever: With 50 years of study, hundreds of thousands of patients and an extremely high disease burden, what have we learned? Curr Opin Virol. 2019;37:123-31.  https://doi.org/10.1016/j.coviro.2019.07.009  PMID: 31479990 
  10. Kofman A, Choi MJ, Rollin PE. Lassa fever in travelers from West Africa, 1969-2016. Emerg Infect Dis. 2019;25(2):245-8.  https://doi.org/10.3201/eid2502.180836  PMID: 30666924 
  11. Ogoina D. Lassa fever: A clinical and epidemiological review. Niger Delta J Med Med Res.2013;1(1):1-10.
  12. Agboeze J, Nwali MI, Nwakpakpa E, Ogah OE, Onoh R, Eze J, et al. Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report. Int J Infect Dis. 2019;89:84-6.  https://doi.org/10.1016/j.ijid.2019.08.023  PMID: 31465848 
  13. World Health Organization (WHO). Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola. Geneva: WHO; 2014. Available from: https://apps.who.int/iris/handle/10665/130596
  14. Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis. 2010;51(12):1435-41.  https://doi.org/10.1086/657315  PMID: 21058912 
  15. Eberhardt KA, Mischlinger J, Jordan S, Groger M, Günther S, Ramharter M. Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis. Int J Infect Dis. 2019;87:15-20.  https://doi.org/10.1016/j.ijid.2019.07.015  PMID: 31357056 
  16. Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, et al. Antibody therapy for Lassa fever. Curr Opin Virol. 2019;37:97-104.  https://doi.org/10.1016/j.coviro.2019.07.003  PMID: 31401518 

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error